Украденный фокус. Почему мы страдаем от дефицита внимания и как сосредоточиться на самом важном - Йоханн Хари

177. S. D. Grosse, T. D. Matte, J. Schwartz and R. J. Jackson, ‘Economic gains resulting from the reduction in children’s exposure to lead in the United States’, Environmental Health Perspectives, 110 (6), 2002, pp. 563–9.

178. Joel Nigg, Getting Ahead of ADHD: What Next-Generation Science Says About Treatments That Work (New York: Guilford Press, 2017), pp. 152–3.

179. Joel Nigg, Getting Ahead of ADHD, pp. 146, 155;

News Desk, ‘BPA rules in European Union now in force: limit strengthened 12 fold’, Food Safety News, 16 September 2018. www.foodsafetynews.com/2018/09/bpa-rules-in-europeanunion-now-in-force-limit-strengthened-12-fold.

180. B. Demeneix, ‘Endrocrine Disruptors: From Scientific Evidence to Human Health Protection’, Policy Department for Citizens’Rights and Constitutional Affairs Directorate General for Internal Policies of the Union, PE 608.866, 2019. www.europarl.europa.eu/thinktank/en/document.html?reference=IPOL_STU%282019%29608866.

181. B. Demeneix, ‘Letter: Chemical pollution is another “asteroid threat” ’, Financial Times, January 11 2020;

B. Demeneix, ‘Environmental factors contribute to loss of IQ’, Financial Times, 18 July 2017.

182. A. Kroll and J. Schulman, ‘Leaked Documents Reveal The Secret Finances of a Pro-Industry Science Group’, Mother Jones, 28 October 2013. www.motherjones.com/politics/2013/10/american-councilscience-health-leaked-documents-fundraising.

183. S. V. Faraone and H. Larsson, ‘Genetics of attention deficit hyperactivity disorder’, Molecular Psychiatry, 24, 2018, pp. 562–75.

184. L. Braitman, Animal Madness: Inside Their Minds (New York: Simon & Schuster, 2015), p. 211.

185. Ibid., p. 196.

186. Это исследование породило огромное количество научных работ. Вот наиболее заметные из них: D. Jacobvitz and L. A. Sroufe, ‘The early caregiver – child relationship and attention deficit disorder with hyperactivity in kindergarten: A prospective study’, Child Development, 58, 1987, pp. 1, 496–504;

E. Carlson, D. Jacobvitz and L. A. Sroufe, ‘A developmental investigation of inattentiveness and hyperactivity’, Child Development, 66, 1995, pp. 37–54.

См. также: A. Sroufe, ‘Ritalin Gone Wrong’, New York Times, 28 January 2012.

187. Alan Sroufe, A Compelling Idea: How We Become the Persons We Are (Brandon, Vermont: Safer Society Press, 2020), pp. 60–5.

См. также: Alan Sroufe The Development of the Person: The Minnesota Study of Risk and Adaptation From Birth to Adulthood (New York: Guilford Press, 2009).

188. Sroufe, A Compelling Idea, p. 63.

189. L. Furman, ‘ADHD: What Do We Really Know?’S. Timimi and J. Leo (eds), Rethinking ADHD: From Brain to Culture (London: Palgrave Macmillan, 2009), p. 57.

190. N. Ezard et al., ‘LiMA: a study protocol for a andomized, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence’, BMJ Open, 2018, 8:e020723.

191. M. G. Kirkpatrick et al., ‘Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans’, Addiction, 107, 4, 2012, pp. 783–91.

192. J. L. Rapoport et al., ‘Dextroamphetamine: Its cognitive and behavioural effects in normal prepubertal boys’, Science, 199, 1978, pp. 560–3;

J. L. Rapoport et al., ‘Dextroamphetamine: Its Cognitive and Behavioral Eff ects in Normal and Hyperactive Boys and Normal Men’, Archives of General Psychiatry, 37, 8, 1980, pp. 933–43;

M. Donnelly and J. Rapoport, ‘Attention Deficit Disorders’, (New York: Wiley, 1985).

См. также: S. W. Garber, Beyond Ritalin: Facts About Medication and other Strategies for Helping Children (New York: Harper Perennial, 1996).

193. D. Rabiner, ‘Consistent use of ADHD medication may stunt growth by 2 inches, large study finds’, Sharp Brains (blog), 16 March 2013. www.sharpbrains.com/blog/2018/03/16/consistent-use-of-adhd-medicationmay-stun-growth-by-2-inches-large-study-finds.

Poulton, ‘Growth on stimulant medication; clarifying the confusion: a review’, Archives of Disease in Childhood, 90, 2005, pp. 801–6.

194. J. Moncrieff, The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment (London: Palgrave Macmillan, 2009), p. 217.

195. A. Sinha et al., ‘Adult ADHD Medications and Their Cardiovascular Implications’, Case Reports in Cardiology, 2016, 2343691;

J.-Y. Shin et al., ‘Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self-controlled case series study’, British Medical Journal, 2016, p. 353.

196. K. van der Marel et al., ‘Long-Term Oral Methylphenidate Treatment in Adolescent and Adult Rats: Differential Effects on Brain Morphology and Function’, Neuropsychopharmacology, 39, 2014, pp. 263–73.

197. ‘A 14-Month Randomised Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder’, Archives of General Psychiatry, 56, 12, 1999, pp. 1073–86.

198. J. Joseph, The Trouble With Twin Studies: A Reassessment of Twin Research in the Social and Behavioral Sciences (Abingdon-on-Thames: Routledge, 2016), pp. 153–78.

199. P. Heiser et al., ‘Twin study on heritability of activity, attention, and impulsivity and assessed by objective measures’, Journal of Attention Disorders, 9, 2006, pp. 575–81;

R. E. Lopez, Hyperactivity in twins’, Canadian Psychiatric Association Journal, 10, 1965, pp. 421–6;

D. K. Sherman et al., ‘Attention-deficit hyperactivity disorder dimensions: A twin study of inattention and impulsivity hyperactivity’, Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1997, pp. 745–53;

A. Thapar et al., ‘Genetic basis of attention-deficit and hyperactivity’, British Journal of Psychiatry, 174, 1999, pp. 105–11.

200. Joseph, The Trouble With Twin Studies, pp. 153–78.

201. ‘It’s Time To Abandon the “Classical Twin Method” in Behavioral Research’, The Gene Illusion (blog), 21 June 2020. www.thegeneillusion.blogspot.com/2020/06/its-time-to-abandon-classical-twin_21.html.

202. D. Demontis et al., ‘Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder’, Nature Genetics, 51, 2019, pp. 63–75.

203. Nigg, Getting Ahead of ADHD, pp. 6–7.

204. Ibid., p. 45.

205. Ibid., p. 41.

206. Ibid., p. 39.

207. Ibid., p. 2.

208. S. L. Hofferth, ‘Changes in American children’s time – 1997 to 2003’, Electronic International Journal of Time-use Research, 6 (1), 2009, pp. 26–47.

См. также: B. Schulte, Overwhelmed: Work, Love and Play When No One Has the Time (London: Bloomsbury, 2014), pp. 207–8;

P. Gray, ‘The decline of play and the rise of psychopathology in children and adolescents’, American Journal of Play, 3 (4), 2011, pp. 443–63;

R. Clements, ‘An Investigation of the Status of Outdoor Play’, Contemporary Issues in Early Childhood, 5 (1), 2004, pp. 68–80.

209. L. Verburgh et al., ‘Physical exercise and executive functions in preadolescent children, adolescents and young adults: a meta-analysis’, British Journal of Sports Medicine, 48, 2014, pp. 973–9;

Y. K. Chang et al., ‘The effects of acute exercise on cognitive performance: a meta-analysis’, Brain Research, 1453, 2012, pp. 87–101;

S. Colcombe and A. F. Kramer, ‘Fitness effects on the cognitive function of older adults: a meta-analytic study’, Psychological Science, 14, 2, 2003, pp. 125–30;

P. D. Tomporowski et al., ‘Exercise and Children’s Intelligence, Cognition, and Academic Achievement’, Educational Psychology Review, 20, 2, 2008, pp. 111–31.

210. M. T.